article Open AccessTop 1% cited
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Annals of the Rheumatic Diseases · 2022 · Vol. 82(1) · pp. 3–18
Josef S Smolen✉(Center for Rheumatology)Robert Landewé(University Medical Center)Sytske Anne Bergstra(Leiden University Medical Center)Andreas Kerschbaumer(Center for Rheumatology)Alexandre Sepriano(Nova Medical (United States))Daniel Aletaha(Center for Rheumatology)Roberto Caporali(University of Milan)Christopher J Edwards(University Hospital Southampton NHS Foundation Trust)Kimme L Hyrich(Manchester Academic Health Science Centre)Janet Pope(Western University)Savia de Souza(The Geneva Association)Tanja Stamm(Statistics Austria)Tsutomu Takeuchi(Keio University)Patrick Verschueren(KU Leuven)Kevin Winthrop(Oregon Health & Science University)Alejandro Balsa(Hospital Universitario La Paz)Joan M. Bathon(NewYork–Presbyterian Hospital)Maya H Buch(Manchester University NHS Foundation Trust)Gerd R Burmester(Charité - Universitätsmedizin Berlin)Frank Buttgereit(Charité - Universitätsmedizin Berlin)Myrna Cardiel(Universidad de Morelia)Katerina Chatzidionysiou(Karolinska University Hospital)Cătălin Codreanu(Hai phong University Of Medicine and Pharmacy)Maurizio Cutolo(Polyclinic Medical Center)Alfons A den Broeder(Radboud University Nijmegen)Khadija El Aoufy(University of Florence)Axel Finckh(University of Geneva)João Eurico Fonseca(University of Lisbon)Jacques‐Eric Gottenberg(Université de Strasbourg)Espen A. Haavardsholm(University of Oslo)Annamaria Iagnocco(A. O. Ordine Mauriziano di Torino)Kim Lauper(University of Geneva)Zhanguo Li(Peking University)Iain B. McInnes(University of Glasgow)Eduardo MyslerPeter Nash(Griffith University)Gyula Poór(Semmelweis University)Gorica Ristić(Military Medical Academy)Felice Rivellese(Centre of Experimental Medicine of the Slovak Academy of Sciences)Andrea Rubbert‐Roth(University of St.Gallen)Hendrik Schulze‐Koops(Center for Rheumatology)Nikolay Stoilov(Medical University of Sofia)Anja Strangfeld(Karolinska University Hospital)Annette H M van der Helm–van Mil(Leiden University Medical Center)Elsa van Duuren(Sefako Makgatho Health Sciences University)T. P. M. Vliet Vlieland(American Physical Therapy Association)René Westhovens(KU Leuven)Désirée van der Heijde(Leiden University Medical Center)
Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical MethodsSystemic Lupus Erythematosus ResearchMedicineAntirheumatic drugsRheumatoid arthritisAntirheumatic AgentsArthritisHydroxychloroquineDiseaseBiological drugsIntensive care medicineImmunology
MeSH terms
Arthritis, RheumatoidBiological ProductsDrug Therapy, CombinationHumansMethotrexateNeoplasmsAntirheumatic AgentsBiosimilar Pharmaceuticals
Funding
- Amgen
- Eli Lilly and Company
- Pfizer
- Sanofi
- Gilead Sciences
- Biogen
- European League Against Rheumatism
- Medac
Citations
1,636
FWCI
232.03
field-weighted impact
References
69
Percentile
100%
vs. same field & year
Citations per year
Cited by
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Annals of the Rheumatic Diseases · 2023 · 803 citations
References
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
Arthritis & Rheumatism · 1998 · 1,638 citations
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Annals of the Rheumatic Diseases · 2010 · 4,780 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases · 2017 · 5,757 citations
Treating rheumatoid arthritis to target: recommendations of an international task force
Annals of the Rheumatic Diseases · 2010 · 2,076 citations
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Annals of the Rheumatic Diseases · 2015 · 1,431 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Annals of the Rheumatic Diseases · 2013 · 1,756 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Annals of the Rheumatic Diseases · 2020 · 2,709 citations
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
Annals of the Rheumatic Diseases · 2011 · 766 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.